Cargando…

Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report

Direct surgical resection remains to be the standard treatment for tuberous sclerosis complex (TSC) with subependymal giant cell astrocytoma (SEGA). Medical therapy with everolimus (mammalian target of rapamycin inhibitor or mTOR) serves as a second-line treatment for patients with SEGA who are dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	KARITA, Hiroki, TSUDA, Kyoji, KONO, Maya, YAMAMOTO, Tetsuya, IHARA, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Neurosurgical Society 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635902/ https://www.ncbi.nlm.nih.gov/pubmed/37953906 http://dx.doi.org/10.2176/jns-nmc.2022-0375

Ejemplares similares

Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis
por: Franz, David N., et al.
Publicado: (2015)

The Effect of Everolimus on Subependymal Giant Cell Astrocytoma (SEGA) in Children with Tuberous Sclerosis Complex
por: BAKHTIARY, Hassan, et al.
Publicado: (2021)

Infantile atypical subependymal giant cell astrocytoma
por: Almubarak, Abdulaziz O., et al.
Publicado: (2020)

Subependymal giant cell astrocytoma: Cytological findings
por: Azarpira, Negar, et al.
Publicado: (2012)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Intraoperative Squash Cytologic Features of Subependymal Giant Cell Astrocytoma
por: Nasit, Jitendra, et al.
Publicado: (2016)

The Clinical Characteristics of Subependymal Giant Cell Astrocytoma: Five Cases
por: Jung, Tae-Young, et al.
Publicado: (2015)

Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
por: Franz, David Neal
Publicado: (2013)

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
por: Fogarasi, Andras, et al.
Publicado: (2016)

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma
por: Bissler, John J., et al.
Publicado: (2017)

Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma
por: Gau, Shuo-Yan, et al.
Publicado: (2023)

Subependymal giant cell astrocytoma (SEGA): a case report and review of the literature
por: Elousrouti, Layla Tahiri, et al.
Publicado: (2016)

Subependymal Giant Cell Astrocytoma Presenting with Tumoral Bleeding: A Case Report
por: Kim, Jae-Young, et al.
Publicado: (2017)

Fetal subependymal giant cell astrocytoma: A case report and review of the literature
por: Karagianni, Aikaterini, et al.
Publicado: (2020)

Imaging Manifestations of a Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis
por: Stein, Joseph R., et al.
Publicado: (2016)

Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case
por: Shelley, India, et al.
Publicado: (2023)

A solitary extraventricular subependymal giant cell astrocytoma in the absence of tuberous sclerosis
por: Tompe, Aparna P., et al.
Publicado: (2020)

Case report: ‘Photodynamics of Subependymal Giant Cell Astrocytoma with 5-Aminolevulinic acid’
por: Ghani, Imran, et al.
Publicado: (2023)

Subependymal Giant Cell Astrocytoma Apoplexy: A Case Report and Systematic Review
por: Turkistani, Alaa N, et al.
Publicado: (2023)

From the bench to the bedside: Everolimus for subependymal giant cell astrocytomas in Tuberous sclerosis complex, optic nerve regeneration, targeted cytotoxins for gliomas
por: Hauptman, Jason S.
Publicado: (2011)

DDEL-06. DRUG INTERACTION BETWEEN EVEROLIMUS AND CANNABIDIOL IN PEDIATRIC PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMAS: A SINGLE INSTITUTION EXPERIENCE
por: Sabus, Ashley, et al.
Publicado: (2020)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex
por: Jansen, Anna C., et al.
Publicado: (2019)

The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas
por: Bongaarts, Anika, et al.
Publicado: (2020)

Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
por: Bongaarts, Anika, et al.
Publicado: (2021)

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

LGG-49. Subependymal giant cell astrocytoma associated with a cortical tuber: A case report
por: Quinot, Valerie Anne, et al.
Publicado: (2022)

Bilateral Renal Angiomyolipomas and Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex: a Case Report and Review of The Literature
por: Rambabova Bushljetik, I, et al.
Publicado: (2021)

Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
por: Major, Philippe
Publicado: (2011)

Late Manifestation of Subependymal Giant Cell Astrocytoma With Hydrocephalus in an Adult Patient With Tuberous Sclerosis Complex
por: Zaher Addeen, Sarah, et al.
Publicado: (2022)

Subependymal giant cell astrocytoma -like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type 1-association
por: Palsgrove, Doreen N., et al.
Publicado: (2018)

LINC-13. Subependymal giant cell astrocytoma in a child with tuberous sclerosis complex: a case report
por: Estetika, Citra, et al.
Publicado: (2022)

Subependymal Giant Cell Astrocytoma: Associated Hyperproteinorrhachia Causing Shunt Failures and Nonobstructive Hydrocephalus - Report of Successful Treatment with Long-term Follow-up
por: Kasper, Ekkehard, et al.
Publicado: (2017)

Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility
por: Tomoto, Kyoichi, et al.
Publicado: (2021)

The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation
por: Tang, Xin, et al.
Publicado: (2021)

Subependymal Giant Cell Astrocytoma Non-Associated With Tuberous Sclerosis Complex and Expression of OCT-4 and INI-1: A Case Report
por: Calderón-Garcidueñas, Ana-Laura, et al.
Publicado: (2023)

Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study
por: Jansen, Anna C., et al.
Publicado: (2019)

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
por: Bongaarts, Anika, et al.
Publicado: (2017)

NFB-16. mTOROPATHIES AND SUBEPENDYMAL GIANT CELL ASTROCYTOMAS: PREDICTIVE VALUE OF GERMINAL TSC1/2 MUTATIONS SCREENING IN FAMILIAL CASES
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2020)

Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro
por: Bongaarts, Anika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjfansakiopb9ahprovimeenh8